Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|BPI-9016M||BPI-9016|BPI 9016||AXL Inhibitor 27 MET Inhibitor 51||BPI-9016M is a small molecule that inhibits MET and AXL and has potential anti-tumor activity (PMID: 29028616, J Clin Oncol 2018 36:15_suppl, e21108-e21108, PMID: 31948451).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||lung non-small cell carcinoma||not applicable||BPI-9016M||Phase I||Actionable||In a Phase I trial, BPI-9016M treatment was well-tolerated in patients with non-small cell lung cancer who had progressed on prior therapy (n=20), and of nineteen evaluable patients, one patient had a partial response and 10 patients experienced stable disease (PMID: 31948451; NCT02478866).||31948451|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|